I have extensive background in urologic cancer research with particular emphasis on experimental therapeutics and combinatorial strategies. My lab works on projects elucidating cell signaling pathways and therapy resistance mechanisms in urologic cancers. Other research interests include the identification and characterization of: 1) the role of androgen receptor signaling in castration and therapy resistance in prostate cancer, 2) the identification and characterization of novel targets and therapeutics in castration-resistant prostate cancer (CRPC), 3) the role of microRNAs in CRPC, and 4) the identification of novel therapeutic targets in bladder cancer. I have current funding from the Department of Defense Prostate Cancer Research Program (DoD-PCRP) and previous funding from the Department of Defense, the American Cancer Society, and the NCI. As an early career researcher, I laid the groundwork for an independent career by developing the technical expertise and collaborations required. In addition, I successfully administered the projects (e.g. staffing, research protections, budget), collaborated with other researchers, and produced peer-reviewed publications from each project.